Sepracor’s Insomnia Drug Enters Europe with GSK Deal
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 88 (Table of Contents)
Published: 7 Oct-2007
DOI: 10.3833/pdr.v2007.i88.279 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Sepracor out-licensed the commercialization rights for insomnia product Lunivia® to GlaxoSmithKline (GSK) which will market the product worldwide excluding US, Canada, Mexico and Japan...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS